Next Article in Journal
Combination of Osimertinib and Olaparib Therapy to Treat Non-Small Cell Lung Cancer and High-Grade Serous Ovarian Carcinoma: A Case Report
Previous Article in Journal
Artemis as Predictive Biomarker of Responsiveness to Preoperative Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer
Previous Article in Special Issue
Adjuvant Sorafenib for Postoperative Patients with Hepatocellular Carcinoma and Macrovascular Invasion
 
 
Article
Peer-Review Record

Comparative Analysis of Subclassification Systems in Patients with Intermediate-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Classification B) Receiving Systemic Therapy

Curr. Oncol. 2024, 31(1), 547-557; https://doi.org/10.3390/curroncol31010038
by Luca Ielasi 1,*, Bernardo Stefanini 2,3, Fabio Conti 1, Matteo Tonnini 2,3, Raffaella Tortora 4, Giulia Magini 5, Rodolfo Sacco 6,7, Tiziana Pressiani 8, Franco Trevisani 2,9, Francesco Giuseppe Foschi 1, Fabio Piscaglia 2,3, Alessandro Granito 2,3 and Francesco Tovoli 2,3
Reviewer 1:
Reviewer 2: Anonymous
Curr. Oncol. 2024, 31(1), 547-557; https://doi.org/10.3390/curroncol31010038
Submission received: 26 November 2023 / Revised: 14 January 2024 / Accepted: 18 January 2024 / Published: 19 January 2024
(This article belongs to the Special Issue Hepatocellular Carcinoma: Epidemiology, Pathogenesis and Treatment)

Round 1

Reviewer 1 Report

Comments and Suggestions for Authors

Thank you for the opportunity to review this manuscript.  The authors present a very nice study comparing the prognostic value of the most used classification systems for intermediate grade HCC.  They find in their patient cohort that certain systems are superior to the others.  They also offer improvement of prognostic accuracy in the two best systems by increasing AFP threshold.  The authors acknowledge limitations of the relatively small sample size in certain subgroups, and that it is retrospective.  Overall, the paper is straight forward and interesting.  It is concisely written, well-referenced, and the statistical methods are appropriate. 

Comments on the Quality of English Language

Quality of English language is excellent.  I offer the following edits:

Pg 2, Ln 47: "third" should be "third leading cause of"

Pg 7, Ln 213: "taht" should be "that"

Pg 8, Ln 253: "little" should be "small"

Pg 8, Ln 259: "come" should be "coming"

Also, small detail, in table 1, the units of DCP and AFP levels should be in the footnote (i.e. mAU/mL and ng/mL)

Author Response

Thanks for your comments. We are pleased to receive your positive feedback.
We modified the document as suggested.

Reviewer 2 Report

Comments and Suggestions for Authors

I thank the editors for giving me the opportunity to review the manuscript by Ielasi et al. In their work, the authors compared different subclassification systems of BCLC B HCC patients receiving systemic therapy. The authors present a overall interesting and sound work with a strong methodological background and clear presentation of the results. I have minor points to address:

- l. 66: I suggest a short description of the up-to-7-criteria for those readers who are not familiar with it.

- Methods: The authors should clarify that this is a retrospective analysis of prospectively entered data.

- Table 2: To what event does age refer? Time of inclusion? Please clarify. Add "in years".

- Table 3: Please expand the table in order to include median overall survival for each subgroup the parameter applies to. 

- Figure 1/2/Suppl. Files: Please add "months" after median overall survival.

- l. 213: spelling error ("that")

Author Response

Thanks for your comments. We are pleased to receive your positive feedback.
We modified the document as suggested.

Back to TopTop